Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma.
Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Sakata K, Matsugaki S, Kajiwara M, Fukuizumi K, Tajiri N, Matsukuma N, Sakai T, Ono N, Yano Y, Koga H, Kurogi J, Takata A, Sumie S, Satani M, Yamada S, Niizeki T, Aino H, Iwamoto H, Torimura T, Sata M. Nakano M, et al. Among authors: matsugaki s. Oncology. 2013;84(2):108-14. doi: 10.1159/000342650. Epub 2012 Nov 9. Oncology. 2013. PMID: 23147476
Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy.
Nagamatsu H, Itano S, Nagaoka S, Akiyoshi J, Matsugaki S, Kurogi J, Tajiri N, Yamasaki S, Koga H, Torimura T, Kumashiro R, Sata M. Nagamatsu H, et al. Among authors: matsugaki s. Am J Gastroenterol. 2004 Dec;99(12):2369-75. doi: 10.1111/j.1572-0241.2004.40069.x. Am J Gastroenterol. 2004. PMID: 15571585
Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.
Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, Kurogi J, Matsugaki S, Inoue K, Tajiri N, Takada A, Ando E, Kuromatsu R, Kaida H, Kurogi M, Koga H, Kumashiro R, Hayabuchi N, Kojiro M, Sata M. Nagaoka S, et al. Among authors: matsugaki s. Liver Int. 2006 Sep;26(7):781-8. doi: 10.1111/j.1478-3231.2006.01296.x. Liver Int. 2006. PMID: 16911459
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma.
Iwamoto H, Niizeki T, Nagamatsu H, Ueshima K, Nomura T, Kuzuya T, Kasai K, Kooka Y, Hiraoka A, Sugimoto R, Yonezawa T, Ishihara A, Deguchi A, Arai H, Shimose S, Shirono T, Nakano M, Okamura S, Noda Y, Kamachi N, Sakai M, Suzuki H, Aino H, Matsukuma N, Matsugaki S, Ogata K, Yano Y, Ueno T, Kajiwara M, Itano S, Fukuizumi K, Kawano H, Noguchi K, Tanaka M, Yamaguchi T, Kuromatsu R, Kawaguchi A, Koga H, Torimura T, New Fp Study Group, Kurume Liver Cancer Study Group Of Japan. Iwamoto H, et al. Among authors: matsugaki s. Cancers (Basel). 2021 Feb 5;13(4):646. doi: 10.3390/cancers13040646. Cancers (Basel). 2021. PMID: 33562793 Free PMC article.
The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Shimose S, Iwamoto H, Shirono T, Tanaka M, Niizeki T, Kajiwara M, Itano S, Yano Y, Matsugaki S, Moriyama E, Noda Y, Nakano M, Kuromatsu R, Koga H, Kawaguchi T. Shimose S, et al. Among authors: matsugaki s. Cancer Med. 2023 Jun;12(11):12325-12335. doi: 10.1002/cam4.5931. Epub 2023 Apr 16. Cancer Med. 2023. PMID: 37062077 Free PMC article.
[A case of IgG4-related sclerosing disorders involving the mesentery and the pancreas].
Sakemi R, So S, Morimitsu Y, Uchiyama D, Kakiuchi S, Ishihara Y, Matsushima Y, Kubo Y, Matsugaki S, Ono T, Takane J, Sasaki E, Sakemi M, Shimokobe M, Sata M. Sakemi R, et al. Among authors: matsugaki s. Nihon Shokakibyo Gakkai Zasshi. 2011 Jun;108(6):969-77. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 21646765 Japanese.
A case of postirradiation angiosarcoma of the greater omentum with hemorrhage.
Sakemi M, Sakemi R, Harada M, So S, Uchiyama D, Morimitsu Y, Kakiuchi S, Ishihara Y, Kubo Y, Matsugaki S, Ono T, Takane J, Sasaki E, Shimokobe M, Sata M. Sakemi M, et al. Among authors: matsugaki s. Clin J Gastroenterol. 2011 Oct;4(5):302-306. doi: 10.1007/s12328-011-0245-6. Epub 2011 Jul 30. Clin J Gastroenterol. 2011. PMID: 26189629
Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.
Nagamatsu H, Sumie S, Niizeki T, Tajiri N, Iwamoto H, Aino H, Nakano M, Shimose S, Satani M, Okamura S, Kuromatsu R, Matsugaki S, Kurogi J, Kajiwara M, Koga H, Torimura T. Nagamatsu H, et al. Among authors: matsugaki s. Cancer Chemother Pharmacol. 2016 Feb;77(2):243-50. doi: 10.1007/s00280-015-2892-7. Epub 2016 Jan 11. Cancer Chemother Pharmacol. 2016. PMID: 26754678 Clinical Trial.
11 results